ArticlePloS one2018
Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment.
Fredrika Koskimäki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papertrialcites it